Release Date: 01/03/11 16:15 Summary: Most Options Exercised and Balance Lapsed Price Sensitive: No Download Document 23.67KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%